Market Place
Sourcing Support
Enforcement Report - Week of February 21, 2024
21 Feb 2024 //
FDA
Aurobindo`s Generic Norethindrone Receives Approval in the U.S.
06 Jan 2023 //
FDA
Myovant touts Pfizer-partnered drug launch plans
30 Jul 2022 //
FIERCEPHARMA
Sumitovant Announces Pub of Myovant Abstracts Detailing Additional Efficacy
29 Apr 2020 //
PR NEWSWIRE
Enforcement Report - Week of January 15, 2020
16 Jan 2020 //
FDA
Enforcement Report - Week of November 14, 2018
14 Nov 2018 //
FDA
Janssen Voluntarily Recalls Ortho-Novum 1/35 and Ortho-Novum 7/7/7
03 Nov 2018 //
FDA
Recipharm Ltd. Fails EDQM Inspection
20 Oct 2018 //
EDQM
Sanofi-Aventis-Withdrawal of Approval of 20 New Drug Applications
19 Oct 2018 //
FEDERAL REGISTER
Allergan Weighs Options for Women`s Health Unit
02 Apr 2018 //
BLOOMBERG
Aurobindo Pharma’s Generic Incassia (Norethindrone) Approved In US
27 Sep 2016 //
FDA
Glenmark gets USFDA tentative nod for oral contraceptives
25 Apr 2016 //
BUSINESS STANDARD
Lupin gets USFDA nod for generic oral contraceptive tablets
24 Nov 2015 //
ECONOMIC TIMES
Mylan Launches First Generic Version of Generess Fe®
07 Apr 2015 //
MYLAN
Famy`s Generic Ethinyl Estradiol and Norethindrone (0.035MG and 0.4MG) Approved in USA For Contraception
01 Apr 2015 //
FAMY CARE LTD
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.